Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 47.57 M48.26 M53.88 M51.69 M51.88 M51.27 M 208.7 M Research & development —————— — Operating income 6.24 M6.02 M60.6 M11.47 M637 K1.8 M 74.5 M Non-Operating Income, Total 1.04 M689 K622 K1.25 M712 K832 K 3.41 M Interest expense, net of interest capitalized 212 K85 K441 K755 K139 K302 K 1.64 M Non-Operating Income, excl. Interest Expenses 825 K604 K181 K493 K573 K530 K 1.78 M Unusual income/expense —————— — Pretax income 7.06 M6.63 M60.78 M11.96 M1.21 M2.33 M 76.28 M Equity in earnings —————— — Taxes 1.92 M1.8 M16.53 M579 K327 K656 K 18.09 M Non-controlling/minority interest —————— — After tax other income/expense 93 K-302 K-3 000117 K100 K-370 K -156 K Net income before discontinued operations 5.14 M4.82 M44.25 M11.38 M883 K1.68 M 58.19 M Discontinued operations —————— — Net income 5.14 M4.82 M44.25 M11.38 M883 K1.68 M 58.19 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 5.14 M4.82 M44.25 M11.38 M883 K1.68 M 58.19 M Basic earnings per share (Basic EPS) 0.260.252.270.590.050.09 3 Diluted earnings per share (Diluted EPS) 0.260.252.260.590.050.09 2.99 Average basic shares outstanding 19.47 M19.49 M19.45 M19.47 M19.32 M18.91 M — Diluted shares outstanding 19.56 M19.56 M19.54 M19.55 M19.43 M18.93 M — EBITDA 23.98 M23.79 M79.25 M30.63 M19.32 M20.72 M 149.93 M EBIT 6.24 M6.02 M60.6 M11.47 M637 K1.8 M 74.5 M Cost of revenue 268.7 M260.4 M304.25 M280.01 M247.77 M245.53 M 1.08 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 17.74 M17.77 M18.66 M19.16 M18.68 M18.91 M 75.42 M